TARDBP and amyotrophic lateral sclerosis: ALS patients exhibit strong TDP-43 pathology in the motor cortex, spinal cord and basal ganglia, while FTLD-TDP patients show TDP-43 expression throughout the central nervous system (CNS), except for the occipital cortex and cerebellum [12].